🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to evaluate safety and efficacy of three doses ...
Status
Completed
Location
P3 Research
Start Date
2007-02
Trial ID
NCT00439621
Treatments Being Tested
This research is being done to study the effects of the drug omalizumab (Xo...
Status
Completed
Location
Johns Hopkins Asthma and Allergy Center
Start Date
2007-07
Trial ID
NCT00604786
Treatments Being Tested
Elevated levels of immunoglobuline E in blood are said to promote the occur...
Status
Completed
Location
Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, Austria.
Start Date
2001-10
Trial ID
NCT00822783
Treatments Being Tested
This study will assess the efficacy, safety and tolerability of omalizumab,...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-09
Trial ID
NCT01202903
Treatments Being Tested
The study is designed to explore the mode of action for omalizumab therapy ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-04
Trial ID
NCT01599637
A substance called immunoglobulin E (IgE), which is naturally produced by o...
Status
Completed
Location
Alabama Allergy and Asthma Center
Start Date
2004-04
Trial ID
NCT00079937
Treatments Being Tested
An open-label, randomized, in parallel groups comparative study of pharmaco...
Status
Completed
Location
State budgetary institution of health care of the city of Moscow "City outpatients clinic No. 2 of the Department of Health of the city of Moscow"
Start Date
2017-04-18
Trial ID
NCT04601389
Treatments Being Tested
The purpose of this study is to determine the efficacy and safety of omaliz...
Status
Completed
Location
Jonathan Corren MD, Inc.
Start Date
2017-11-15
Trial ID
NCT03280550
Treatments Being Tested
Background: AD-HIES is a disease that weakens the immune system. It puts p...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2016-11-17
Trial ID
NCT02996448
Treatments Being Tested
In this project, the investigators would like to learn if 24 weeks (about 5...
Status
Recruiting
Location
Johns Hopkins
Start Date
2025-05-19
Trial ID
NCT06934200
Treatments Being Tested